{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:07:48Z","timestamp":1790856468661,"version":"4.1.0"},"reference-count":76,"publisher":"Bentham Science Publishers Ltd.","issue":"11","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>14-3-3s constitute a group of proteins belonging to the phosphoserine\/phosphothreonine\nfamily that are involved in the regulation of several physiological pathways by interacting\nwith several client proteins. All the eukaryotic cells are known to possess 14-3-3 isoforms. In addition,\n14-3-3s isolated from different eukaryotic cells share high sequence homology with each\nother. Seven isoforms (&amp;#946;, &amp;#947;, &amp;#949;, &amp;#951;, &amp;#950;, &amp;#963;, and &amp;#964;\/&amp;#952;) have been yet identified in mammals. These proteins\nparticipate in several physiological processes by either stimulating or interfering with the enzymatic\nactivities of binding partners. These proteins take part in several human diseases upon dysregulation\nwhich include cancer and neurodegenerative disorders. Recently, a number of evidences\nsuggest that the interaction of 14-3-3s with either oncogenic or pro-apoptotic proteins can\nlead to cancer development in animals. In the case of neurodegenerative disorders, 14-3-3s interact\nwith Lewy bodies and neurofibrillary tangles in Parkinson\u2019s and Alzheimer\u2019s diseases, respectively.\nThe current review focuses on strategies to regulate 14-3-3s\u2019 proteins in diseases. Potential\nstrategies to regulate 14-3-3 interactions in disease conditions include the use of small interfering\nRNAs (siRNA), microRNA (miRNA), and modifications of 14-3-3s or their client proteins. In addition,\nsome peptides or chemicals can also serve as potential inhibitors of 14-3-3. However, optimization\nof these therapeutic strategies is required for their practical implementations.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298665330728241025082011","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T04:24:47Z","timestamp":1732681487000},"page":"850-861","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Recent Trends in Development of Novel Therapeutics for Modulation of 14-3-3 Protein-Protein Interactions in Diseases"],"prefix":"10.2174","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6128-2924","authenticated-orcid":true,"given":"Arshia","family":"Nazir","sequence":"first","affiliation":[{"name":"School of Biological Sciences, University of the Punjab, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.tips.2021.01.001","volume":"42","author":"Pair F.S.","year":"2021","unstructured":"Pair F.S.; Yacoubian T.A.; 14-3-3 Proteins: Novel pharmacological targets in neurodegenerative diseases. Trends Pharmacol Sci  2021,42(4),226-238","journal-title":"Trends Pharmacol Sci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/bs.pmbts.2019.03.007","volume":"166","author":"Sluchanko N.N.","year":"2019","unstructured":"Sluchanko N.N.; Bustos D.M.; Intrinsic disorder associated with 14-3-3 proteins and their partners. Prog Mol Biol Transl Sci  2019,166,19-61","journal-title":"Prog Mol Biol Transl Sci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.molcel.2011.07.028","volume":"43","author":"Andersen J.L.","year":"2011","unstructured":"Andersen J.L.; Thompson J.W.; Lindblom K.R.; Johnson E.S.; Yang C.S.; Lilley L.R.; Freel C.D.; Moseley M.A.; Kornbluth S.; A biotin switch-based proteomics approach identifies 14-3-3\u03b6 as a target of Sirt1 in the metabolic regulation of caspase-2. Mol Cell  2011,43(5),834-842","journal-title":"Mol Cell"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"5587","DOI":"10.1038\/s41388-018-0348-3","volume":"37","author":"Pennington K.L.","year":"2018","unstructured":"Pennington K.L.; Chan T.Y.; Torres M.P.; Andersen J.L.; The dynamic and stress-adaptive signaling hub of 14-3-3: Emerging mechanisms of regulation and context-dependent protein\u2013protein interactions. Oncogene  2018,37(42),5587-5604","journal-title":"Oncogene"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1021\/acs.jmedchem.7b00574","volume":"61","author":"Stevers L.M.","year":"2018","unstructured":"Stevers L.M.; Sijbesma E.; Botta M.; MacKintosh C.; Obsil T.; Landrieu I.; Cau Y.; Wilson A.J.; Karawajczyk A.; Eickhoff J.; Davis J.; Hann M.; O\u2019Mahony G.; Doveston R.G.; Brunsveld L.; Ottmann C.; Modulators of 14-3-3 protein-protein interactions. J Med Chem  2018,61(9),3755-3778","journal-title":"J Med Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"16305","DOI":"10.1074\/jbc.273.26.16305","volume":"273","author":"Petosa C.","year":"1998","unstructured":"Petosa C.; Masters S.C.; Bankston L.A.; Pohl J.; Wang B.; Fu H.; Liddington R.C.; 14-3-3zeta binds a phosphorylated Raf peptide and an unphosphorylated peptide via its conserved amphipathic groove. J Biol Chem  1998,273(26),16305-16310","journal-title":"J Biol Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11940-016-0424-3","volume":"18","author":"Ooms S.","year":"2016","unstructured":"Ooms S.; Ju Y.E.; Treatment of sleep disorders in dementia. Curr Treat Options Neurol  2016,18(9),40","journal-title":"Curr Treat Options Neurol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.bbapap.2014.12.019","volume":"1854","author":"Bakthisaran R.","year":"2015","unstructured":"Bakthisaran R.; Tangirala R.; Rao C.M.; Small heat shock proteins: Role in cellular functions and pathology. Biochim Biophys Acta Proteins Proteomics  2015,1854(4),291-319","journal-title":"Biochim Biophys Acta Proteins Proteomics"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.str.2016.12.005","volume":"25","author":"Sluchanko N.N.","year":"2017","unstructured":"Sluchanko N.N.; Beelen S.; Kulikova A.A.; Weeks S.D.; Antson A.A.; Gusev N.B.; Strelkov S.V.; Structural basis for the interaction of a human small heat shock protein with the 14-3-3 universal signaling regulator. Structure  2017,25(2),305-316","journal-title":"Structure"},{"key":"ref=10","first-page":"7030","volume":"61","author":"Stavridi E.S.","year":"2001","unstructured":"Stavridi E.S.; Chehab N.H.; Malikzay A.; Halazonetis T.D.; Substitutions that compromise the ionizing radiation-induced association of p53 with 14-3-3 proteins also compromise the ability of p53 to induce cell cycle arrest. Cancer Res  2001,61(19),7030-7033","journal-title":"Cancer Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"e0135976","DOI":"10.1371\/journal.pone.0135976","volume":"10","author":"Ghosh A.","year":"2015","unstructured":"Ghosh A.; Ratha B.N.; Gayen N.; Mroue K.H.; Kar R.K.; Mandal A.K.; Bhunia A.; Biophysical characterization of essential phosphorylation at the flexible C-terminal region of C-Raf with 14-3-3 \u03b6 protein. PLoS One  2015,10(8),e0135976","journal-title":"PLoS One"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.3390\/ijms20143518","volume":"20","author":"Fan X.","year":"2019","unstructured":"Fan X.; Cui L.; Zeng Y.; Song W.; Gaur U.; Yang M.; 14-3-3 proteins are on the crossroads of cancer, aging, and age-related neurodegenerative disease. Int J Mol Sci  2019,20(14),3518","journal-title":"Int J Mol Sci"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1158\/0008-5472.CAN-08-2765","volume":"69","author":"Neal C.L.","year":"2009","unstructured":"Neal C.L.; Yao J.; Yang W.; Zhou X.; Nguyen N.T.; Lu J.; Danes C.G.; Guo H.; Lan K.H.; Ensor J.; Hittelman W.; Hung M.C.; Yu D.; 14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival. Cancer Res  2009,69(8),3425-3432","journal-title":"Cancer Res"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/onc.2011.284","volume":"31","author":"Neal C.L.","year":"2012","unstructured":"Neal C.L.; Xu J.; Li P.; Mori S.; Yang J.; Neal N.N.; Zhou X.; Wyszomierski S.L.; Yu D.; Overexpression of 14-3-3\u03b6 in cancer cells activates PI3K via binding the p85 regulatory subunit. Oncogene  2012,31(7),897-906","journal-title":"Oncogene"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"e1537","DOI":"10.1038\/cddis.2014.501","volume":"5","author":"Lee J-J.","year":"2014","unstructured":"Lee J-J.; Lee J-S.; Cui M.N.; Yun H.H.; Kim H.Y.; Lee S.H.; Lee J-H.; BIS targeting induces cellular senescence through the regulation of 14-3-3 zeta\/STAT3\/SKP2\/p27 in glioblastoma cells. Cell Death Dis  2014,5(11),e1537","journal-title":"Cell Death Dis"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1210\/rp.56.1.127","volume":"56","author":"Avruch J.","year":"2001","unstructured":"Avruch J.; Khokhlatchev A.; Kyriakis J.M.; Luo Z.; Tzivion G.; Vavvas D.; Zhang X.F.; Ras activation of the Raf kinase: Tyrosine kinase recruitment of the MAP kinase cascade. Recent Prog Horm Res  2001,56(1),127-156","journal-title":"Recent Prog Horm Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","volume":"13","author":"Zhang Y.","year":"2020","unstructured":"Zhang Y.; Wang X.; Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer. J Hematol Oncol  2020,13(1),165","journal-title":"J Hematol Oncol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10620-012-2341-y","volume":"58","author":"Yan L.","year":"2013","unstructured":"Yan L.; Gu H.; Li J.; Xu M.; Liu T.; Shen Y.; Chen B.; Zhang G.; RKIP and 14-3-3\u03b5 exert an opposite effect on human gastric cancer cells SGC7901 by regulating the ERK\/MAPK pathway differently. Dig Dis Sci  2013,58(2),389-396","journal-title":"Dig Dis Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.18632\/oncotarget.27700","volume":"11","author":"Holmes T.R.","year":"2020","unstructured":"Holmes T.R.; Al-Matouq J.; Holmes M.; Nicola L.; Rudd J.C.; Lovas S.; Hansen L.A.; Targeting 14-3-3\u03b5-CDC25A interactions to trigger apoptotic cell death in skin cancer. Oncotarget  2020,11(35),3267-3278","journal-title":"Oncotarget"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1038\/sj.onc.1204438","volume":"20","author":"Umbricht C.B.","year":"2001","unstructured":"Umbricht C.B.; Evron E.; Gabrielson E.; Ferguson A.; Marks J.; Sukumar S.; Hypermethylation of 14-3-3 \u03c3 (stratifin) is an early event in breast cancer. Oncogene  2001,20(26),3348-3353","journal-title":"Oncogene"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.neuron.2006.08.014","volume":"51","author":"Li Y.","year":"2006","unstructured":"Li Y.; Wu Y.; Zhou Y.; Modulation of inactivation properties of CaV2.2 channels by 14-3-3 proteins. Neuron  2006,51(6),755-771","journal-title":"Neuron"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"25247","DOI":"10.1074\/jbc.M003738200","volume":"275","author":"Hashiguchi M.","year":"2000","unstructured":"Hashiguchi M.; Sobue K.; Paudel H.K.; 14-3-3zeta is an effector of tau protein phosphorylation. J Biol Chem  2000,275(33),25247-25254","journal-title":"J Biol Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/jnen\/61.3.245","volume":"61","author":"Kawamoto Y.","year":"2002","unstructured":"Kawamoto Y.; Akiguchi I.; Nakamura S.; Honjyo Y.; Shibasaki H.; Budka H.; 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains. J Neuropathol Exp Neurol  2002,61(3),245-253","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrc1230","volume":"3","author":"Hermeking H.","year":"2003","unstructured":"Hermeking H.; The 14-3-3 cancer connection. Nat Rev Cancer  2003,3(12),931-943","journal-title":"Nat Rev Cancer"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1186\/s12885-015-1856-y","volume":"15","author":"Young G.M.","year":"2015","unstructured":"Young G.M.; Radhakrishnan V.M.; Centuori S.M.; Gomes C.J.; Martinez J.D.; Comparative analysis of 14-3-3 isoform expression and epigenetic alterations in colorectal cancer. BMC Cancer  2015,15(1),826","journal-title":"BMC Cancer"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/ijc.24346","volume":"125","author":"Lin M.","year":"2009","unstructured":"Lin M.; Morrison C.D.; Jones S.; Mohamed N.; Bacher J.; Plass C.; Copy number gain and oncogenic activity of YWHAZ\/14-3-3\u03b6 in head and neck squamous cell carcinoma. Int J Cancer  2009,125(3),603-611","journal-title":"Int J Cancer"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"23791","DOI":"10.1038\/srep23791","volume":"6","author":"Qing Y.","year":"2016","unstructured":"Qing Y.; Sun L.; Yang C.; Jiang J.; Yang X.; Hu X.; Cui D.; Xu Y.; He L.; Han D.; Wan C.; Dysregulated 14-3-3 family in peripheral blood leukocytes of patients with schizophrenia. Sci Rep  2016,6(1),23791","journal-title":"Sci Rep"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1074\/mcp.M110.005322","volume":"10","author":"Leivonen S. K.","year":"2011","unstructured":"Leivonen S. K.; Rokka A.; Ostling P.; Kohonen P.; Corthals G. L.; Kallioniemi O.; Perala M.; Identification of miR-193b targets in breast cancer cells and systems biological analysis of their functional impact. Mol Cell Proteomics  2011,10(7),5322","journal-title":"Mol Cell Proteomics"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1158\/0008-5472.CAN-09-2777","volume":"70","author":"Tsukamoto Y.","year":"2010","unstructured":"Tsukamoto Y.; Nakada C.; Noguchi T.; Tanigawa M.; Nguyen L.T.; Uchida T.; Hijiya N.; Matsuura K.; Fujioka T.; Seto M.; Moriyama M.; MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res  2010,70(6),2339-2349","journal-title":"Cancer Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.3892\/mmr.2014.2605","volume":"10","author":"Gong X.","year":"2014","unstructured":"Gong X.; Yan L.; Gu H.; Mu Y.; Tong G.; Zhang G.; 14-3-3\u025b functions as an oncogene in SGC7901 gastric cancer cells through involvement of cyclin E and p27kip1. Mol Med Rep  2014,10(6),3145-3150","journal-title":"Mol Med Rep"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1021\/jacsau.3c00774","volume":"4","author":"Varl\u0131 M.","year":"2024","unstructured":"Varl\u0131 M.; Bhosle S.R.; Kim E.; Yang Y.; Ta\u015f \u0130.; Zhou R.; Pulat S.; Gamage C.D.B.; Park S.Y.; Ha H.H.; Kim H.; Usnic acid targets 14-3-3 proteins and suppresses cancer progression by blocking substrate interaction. JACS Au  2024,4(4),1521-1537","journal-title":"JACS Au"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1023\/A:1023011609931","volume":"22","author":"Moosavi-Movahedi A.A.","year":"2003","unstructured":"Moosavi-Movahedi A.A.; Chamani J.; Ghourchian H.; Shafiey H.; Sorenson C.M.; Sheibani N.; Electrochemical evidence for the molten globule states of cytochrome c induced by N-alkyl sulfates at low concentrations. J Protein Chem  2003,22(1),23-30","journal-title":"J Protein Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s10895-023-03169-4","volume":"33","author":"Malek-Esfandiari Z.","year":"2023","unstructured":"Malek-Esfandiari Z.; Rezvani-Noghani A.; Sohrabi T.; Mokaberi P.; Amiri-Tehranizadeh Z.; Chamani J.; Molecular dynamics and multi-spectroscopic of the interaction behavior between bladder cancer cells and calf thymus DNA with Rebeccamycin: Apoptosis through the down regulation of pi3k\/akt signaling pathway. J Fluoresc  2023,33(4),1537-1557","journal-title":"J Fluoresc"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"123815","DOI":"10.1016\/j.saa.2023.123815","volume":"309","author":"Kaffash M.","year":"2024","unstructured":"Kaffash M.; Tolou-Shikhzadeh-Yazdi S.; Soleimani S.; Hoseinpoor S.; Saberi M.R.; Chamani J.; Spectroscopy and molecular simulation on the interaction of Nano-Kaempferol prepared by oil-in-water with two carrier proteins: An investigation of protein\u2013protein interaction. Spectrochim Acta A Mol Biomol Spectrosc  2024,309,123815","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.drudis.2011.02.002","volume":"16","author":"Edfeldt F.N.B.","year":"2011","unstructured":"Edfeldt F.N.B.; Folmer R.H.A.; Breeze A.L.; Fragment screening to predict druggability (ligandability) and lead discovery success. Drug Discov Today  2011,16(7-8),284-287","journal-title":"Drug Discov Today"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.chembiol.2011.12.013","volume":"19","author":"Surade S.","year":"2012","unstructured":"Surade S.; Blundell T.L.; Structural biology and drug discovery of difficult targets: the limits of ligandability. Chem Biol  2012,19(1),42-50","journal-title":"Chem Biol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/bio.4360","volume":"37","author":"Kalhori F.","year":"2022","unstructured":"Kalhori F.; Yazdyani H.; Khademorezaeian F.; Hamzkanloo N.; Mokaberi P.; Hosseini S.; Chamani J.; Enzyme activity inhibition properties of new cellulose nanocrystals from Citrus medica L. pericarp: A perspective of cholesterol lowering. Luminescence  2022,37(11),1836-1845","journal-title":"Luminescence"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"Szklarczyk D.","year":"2023","unstructured":"Szklarczyk D.; Kirsch R.; Koutrouli M.; Nastou K.; Mehryary F.; Hachilif R.; Gable A.L.; Fang T.; Doncheva N.T.; Pyysalo S.; Bork P.; Jensen L.J.; von Mering C.; The STRING database in 2023: Protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res  2023,51(D1),D638-D646","journal-title":"Nucleic Acids Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"6127","DOI":"10.1021\/bi300674e","volume":"51","author":"Sluchanko N.N.","year":"2012","unstructured":"Sluchanko N.N.; Artemova N.V.; Sudnitsyna M.V.; Safenkova I.V.; Antson A.A.; Levitsky D.I.; Gusev N.B.; Monomeric 14-3-3\u03b6 has a chaperone-like activity and is stabilized by phosphorylated HspB6. Biochemistry  2012,51(31),6127-6138","journal-title":"Biochemistry"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1083\/jcb.200409117","volume":"170","author":"Sunayama J.","year":"2005","unstructured":"Sunayama J.; Tsuruta F.; Masuyama N.; Gotoh Y.; JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. J Cell Biol  2005,170(2),295-304","journal-title":"J Cell Biol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10495-014-1071-3","volume":"20","author":"Wang J.","year":"2015","unstructured":"Wang J.; Liu S.; Yin Y.; Li M.; Wang B.; Yang L.; Jiang Y.; FOXO3-mediated up-regulation of Bim contributes to rhein-induced cancer cell apoptosis. Apoptosis  2015,20(3),399-409","journal-title":"Apoptosis"},{"key":"ref=42","first-page":"609","volume":"12","author":"Rommel C.","year":"1996","unstructured":"Rommel C.; Radziwill G.; Lovri\u0107 J.; Noeldeke J.; Heinicke T.; Jones D.; Aitken A.; Moelling K.; Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1. Oncogene  1996,12(3),609-619","journal-title":"Oncogene"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"28882","DOI":"10.1074\/jbc.272.46.28882","volume":"272","author":"Dubois T.","year":"1997","unstructured":"Dubois T.; Rommel C.; Howell S.; Steinhussen U.; Soneji Y.; Morrice N.; Moelling K.; Aitken A.; 14-3-3 is phosphorylated by casein kinase I on residue 233. Phosphorylation at this site in vivo regulates Raf\/14-3-3 interaction. J Biol Chem  1997,272(46),28882-28888","journal-title":"J Biol Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40364-022-00361-9","volume":"10","author":"Gao C.","year":"2022","unstructured":"Gao C.; Wang S.; Lu J.; Chai X.; Li Y.; Zhang P.; Huang X.; Cai J.; Zheng Y.; Guo X.; Shi G.; Ke A.; Fan J.; KSR2-14\u20133-3\u03b6 complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma. Biomark Res  2022,10(1),25","journal-title":"Biomark Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"6133","DOI":"10.1016\/j.bmcl.2010.08.019","volume":"20","author":"Corradi V.","year":"2010","unstructured":"Corradi V.; Mancini M.; Manetti F.; Petta S.; Santucci M.A.; Botta M.; Identification of the first non-peptidic small molecule inhibitor of the c-Abl\/14-3-3 protein\u2013protein interactions able to drive sensitive and Imatinib-resistant leukemia cells to apoptosis. Bioorg Med Chem Lett  2010,20(20),6133-6137","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1126\/science.1175371","volume":"325","author":"Choudhary C.","year":"2009","unstructured":"Choudhary C.; Kumar C.; Gnad F.; Nielsen M.L.; Rehman M.; Walther T.C.; Olsen J.V.; Mann M.; Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science  2009,325(5942),834-840","journal-title":"Science"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"12487","DOI":"10.1074\/jbc.M114.607580","volume":"290","author":"Mortenson J.B.","year":"2015","unstructured":"Mortenson J.B.; Heppler L.N.; Banks C.J.; Weerasekara V.K.; Whited M.D.; Piccolo S.R.; Johnson W.E.; Thompson J.W.; Andersen J.L.; Histone deacetylase 6 (HDAC6) promotes the pro-survival activity of 14-3-3\u03b6 via deacetylation of lysines within the 14-3-3\u03b6 binding pocket. J Biol Chem  2015,290(20),12487-12496","journal-title":"J Biol Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/ijc.32169","volume":"145","author":"Depetter Y.","year":"2019","unstructured":"Depetter Y.; Geurs S.; De Vreese R.; Goethals S.; Vandoorn E.; Laevens A.; Steenbrugge J.; Meyer E.; de Tullio P.; Bracke M.; D\u2019hooghe M.; De Wever O.; Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models. Int J Cancer  2019,145(3),735-747","journal-title":"Int J Cancer"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1042\/BJ20091834","volume":"427","author":"Johnson C.","year":"2010","unstructured":"Johnson C.; Crowther S.; Stafford M.J.; Campbell D.G.; Toth R.; MacKintosh C.; Bioinformatic and experimental survey of 14-3-3-binding sites. Biochem J  2010,427(1),69-78","journal-title":"Biochem J"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"e4574","DOI":"10.1002\/pro.4574","volume":"32","author":"Zhu P.","year":"2023","unstructured":"Zhu P.; Nguyen K.T.; Estelle A.B.; Sluchanko N.N.; Mehl R.A.; Cooley R.B.; Genetic encoding of 3-nitro-tyrosine reveals the impacts of 14-3-3 nitration on client binding and dephosphorylation. Protein Sci  2023,32(3),e4574","journal-title":"Protein Sci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"e16318","DOI":"10.1016\/j.heliyon.2023.e16318","volume":"9","author":"Li Z.","year":"2023","unstructured":"Li Z.; Huang X.; Li M.; Chen Y.E.; Wang Z.; Liu L.; A ubiquitination-mediated degradation system to target 14-3-3-binding phosphoproteins. Heliyon  2023,9(5),e16318","journal-title":"Heliyon"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.1021\/acs.biochem.7b00153","volume":"56","author":"Sijbesma E.","year":"2017","unstructured":"Sijbesma E.; Skora L.; Leysen S.; Brunsveld L.; Koch U.; Nussbaumer P.; Jahnke W.; Ottmann C.; Identification of two secondary ligand binding sites in 14-3-3 proteins using fragment screening. Biochemistry  2017,56(30),3972-3982","journal-title":"Biochemistry"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"12499","DOI":"10.1021\/bi991353h","volume":"38","author":"Wang B.","year":"1999","unstructured":"Wang B.; Yang H.; Liu Y.C.; Jelinek T.; Zhang L.; Ruoslahti E.; Fu H.; Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display. Biochemistry  1999,38(38),12499-12504","journal-title":"Biochemistry"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1016071","DOI":"10.3389\/fmolb.2022.1016071","volume":"9","author":"Obsilova V.","year":"2022","unstructured":"Obsilova V.; Obsil T.; Structural insights into the functional roles of 14-3-3 proteins. Front Mol Biosci  2022,9,1016071","journal-title":"Front Mol Biosci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"45193","DOI":"10.1074\/jbc.M105971200","volume":"276","author":"Masters S.C.","year":"2001","unstructured":"Masters S.C.; Fu H.; 14-3-3 proteins mediate an essential anti-apoptotic signal. J Biol Chem  2001,276(48),45193-45200","journal-title":"J Biol Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s10495-009-0437-4","volume":"15","author":"Cao W.","year":"2010","unstructured":"Cao W.; Yang X.; Zhou J.; Teng Z.; Cao L.; Zhang X.; Fei Z.; Targeting 14-3-3 protein, difopein induces apoptosis of human glioma cells and suppresses tumor growth in mice. Apoptosis  2010,15(2),230-241","journal-title":"Apoptosis"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3389\/fendo.2019.00797","volume":"10","author":"Zhao S.","year":"2019","unstructured":"Zhao S.; Li B.; Li C.; Gao H.; Miao Y.; He Y.; Wang H.; Gong L.; Li D.; Zhang Y.; Feng J.; The apoptosis regulator 14-3-3\u03b7 and its potential as a therapeutic target in pituitary oncocytoma. Front Endocrinol  2019,10,797","journal-title":"Front Endocrinol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1002\/anie.201310082","volume":"53","author":"Glas A.","year":"2014","unstructured":"Glas A.; Bier D.; Hahne G.; Rademacher C.; Ottmann C.; Grossmann T.N.; Constrained peptides with target-adapted cross-links as inhibitors of a pathogenic protein-protein interaction. Angew Chem Int Ed  2014,53(9),2489-2493","journal-title":"Angew Chem Int Ed"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1002\/cbic.201600362","volume":"17","author":"Cromm P.M.","year":"2016","unstructured":"Cromm P.M.; Wallraven K.; Glas A.; Bier D.; F\u00fcrstner A.; Ottmann C.; Grossmann T.N.; Constraining an irregular peptide secondary structure through ring-closing alkyne metathesis. ChemBioChem  2016,17(20),1915-1919","journal-title":"ChemBioChem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1016\/j.febslet.2009.07.043","volume":"583","author":"Sluchanko N.N.","year":"2009","unstructured":"Sluchanko N.N.; Seit-Nebi A.S.; Gusev N.B.; Phosphorylation of more than one site is required for tight interaction of human tau protein with 14-3-3\u03b6. FEBS Lett  2009,583(17),2739-2742","journal-title":"FEBS Lett"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1096\/fj.14-265009","volume":"29","author":"Joo Y.","year":"2015","unstructured":"Joo Y.; Schumacher B.; Landrieu I.; Bartel M.; Smet-Nocca C.; Jang A.; Choi H.S.; Jeon N.L.; Chang K.A.; Kim H.S.; Ottmann C.; Suh Y.H.; Involvement of 14-3-3 in tubulin instability and impaired axon development is mediated by Tau. FASEB J  2015,29(10),4133-4144","journal-title":"FASEB J"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"15720","DOI":"10.1002\/anie.201507976","volume":"54","author":"Milroy L.G.","year":"2015","unstructured":"Milroy L.G.; Bartel M.; Henen M.A.; Leysen S.; Adriaans J.M.C.; Brunsveld L.; Landrieu I.; Ottmann C.; Stabilizer-guided inhibition of protein-protein interactions. Angew Chem Int Ed  2015,54(52),15720-15724","journal-title":"Angew Chem Int Ed"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cbpa.2006.11.031","volume":"11","author":"Duffner J.L.","year":"2007","unstructured":"Duffner J.L.; Clemons P.A.; Koehler A.N.; A pipeline for ligand discovery using small-molecule microarrays. Curr Opin Chem Biol  2007,11(1),74-82","journal-title":"Curr Opin Chem Biol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"6528","DOI":"10.1002\/anie.201003257","volume":"49","author":"Wu H.","year":"2010","unstructured":"Wu H.; Ge J.; Yao S.Q.; Microarray-assisted high-throughput identification of a cell-permeable small-molecule binder of 14-3-3 proteins. Angew Chem Int Ed  2010,49(37),6528-6532","journal-title":"Angew Chem Int Ed"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.chembiol.2012.05.011","volume":"19","author":"Arrendale A.","year":"2012","unstructured":"Arrendale A.; Kim K.; Choi J.Y.; Li W.; Geahlen R.L.; Borch R.F.; Synthesis of a phosphoserine mimetic prodrug with potent 14-3-3 protein inhibitory activity. Chem Biol  2012,19(6),764-771","journal-title":"Chem Biol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1124\/jpet.110.172536","volume":"336","author":"Mancini M.","year":"2011","unstructured":"Mancini M.; Corradi V.; Petta S.; Barbieri E.; Manetti F.; Botta M.; Santucci M.A.; A new nonpeptidic inhibitor of 14-3-3 induces apoptotic cell death in chronic myeloid leukemia sensitive or resistant to imatinib. J Pharmacol Exp Ther  2011,336(3),596-604","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.bmcl.2015.12.066","volume":"26","author":"Valensin D.","year":"2016","unstructured":"Valensin D.; Cau Y.; Calandro P.; Vignaroli G.; Dello Iacono L.; Chiariello M.; Mori M.; Botta M.; Molecular insights to the bioactive form of BV02, a reference inhibitor of 14-3-3\u03c3 protein\u2013protein interactions. Bioorg Med Chem Lett  2016,26(3),894-898","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/14756366.2019.1574779","volume":"34","author":"Iralde-Lorente L.","year":"2019","unstructured":"Iralde-Lorente L.; Cau Y.; Clementi L.; Franci L.; Tassone G.; Valensin D.; Mori M.; Angelucci A.; Chiariello M.; Botta M.; Chemically stable inhibitors of 14-3-3 protein\u2013protein interactions derived from BV02. J Enzyme Inhib Med Chem  2019,34(1),657-664","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/cmdc.201400044","volume":"9","author":"Mori M.","year":"2014","unstructured":"Mori M.; Vignaroli G.; Cau Y.; Dini\u0107 J.; Hill R.; Rossi M.; Colecchia D.; Pe\u0161i\u0107 M.; Link W.; Chiariello M.; Ottmann C.; Botta M.; Discovery of 14-3-3 protein-protein interaction inhibitors that sensitize multidrug-resistant cancer cells to doxorubicin and the Akt inhibitor GSK690693. ChemMedChem  2014,9(5),973-983","journal-title":"ChemMedChem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"16212","DOI":"10.1073\/pnas.1100012108","volume":"108","author":"Zhao J.","year":"2011","unstructured":"Zhao J.; Du Y.; Horton J.R.; Upadhyay A.K.; Lou B.; Bai Y.; Zhang X.; Du L.; Li M.; Wang B.; Zhang L.; Barbieri J.T.; Khuri F.R.; Cheng X.; Fu H.; Discovery and structural characterization of a small molecule 14-3-3 protein-protein interaction inhibitor. Proc Natl Acad Sci USA  2011,108(39),16212-16216","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"E1051","DOI":"10.1073\/pnas.1116592109","volume":"109","author":"R\u00f6glin L.","year":"2012","unstructured":"R\u00f6glin L.; Thiel P.; Kohlbacher O.; Ottmann C.; Covalent attachment of pyridoxal-phosphate derivatives to 14-3-3 proteins. Proc Natl Acad Sci USA  2012,109(18),E1051-E1053","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.chembiol.2005.09.017","volume":"12","author":"Takemoto Y.","year":"2005","unstructured":"Takemoto Y.; Watanabe H.; Uchida K.; Matsumura K.; Nakae K.; Tashiro E.; Shindo K.; Kitahara T.; Imoto M.; Chemistry and biology of moverastins, inhibitors of cancer cell migration, produced by Aspergillus. Chem Biol  2005,12(12),1337-1347","journal-title":"Chem Biol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"39259","DOI":"10.1074\/jbc.M111.255489","volume":"286","author":"Kobayashi H.","year":"2011","unstructured":"Kobayashi H.; Ogura Y.; Sawada M.; Nakayama R.; Takano K.; Minato Y.; Takemoto Y.; Tashiro E.; Watanabe H.; Imoto M.; Involvement of 14-3-3 proteins in the second epidermal growth factor-induced wave of Rac1 activation in the process of cell migration. J Biol Chem  2011,286(45),39259-39268","journal-title":"J Biol Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1016\/j.bmc.2016.04.014","volume":"24","author":"Tashiro E.","year":"2016","unstructured":"Tashiro E.; Imoto M.; Screening and target identification of bioactive compounds that modulate cell migration and autophagy. Bioorg Med Chem  2016,24(15),3283-3290","journal-title":"Bioorg Med Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fchem.2019.00237","volume":"7","author":"Shi M.","year":"2019","unstructured":"Shi M.; Xu D.; Molecular dynamics investigations suggest a non-specific recognition strategy of 14-3-3\u03c3 protein by tweezer: Implication for the inhibition mechanism. Front Chem  2019,7,237","journal-title":"Front Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"921695","DOI":"10.3389\/fchem.2022.921695","volume":"10","author":"Zhou X.","year":"2022","unstructured":"Zhou X.; Shi M.; Wang X.; Xu D.; Exploring the binding mechanism of a supramolecular tweezer CLR01 to 14-3-3 \u03c3 protein via well-tempered metadynamics. Front Chem  2022,10,921695","journal-title":"Front Chem"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298665330728241025082011","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/236570\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298665330728241025082011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T10:55:50Z","timestamp":1737024950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/236570\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":76,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298665330728241025082011","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-05-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}